Clinical Activity of Sunitinib and Regorafenib in Endometriosis

Mayo Clin Proc. 2019 Dec;94(12):2591-2593. doi: 10.1016/j.mayocp.2019.10.001.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Endometriosis / drug therapy
  • Endometriosis / etiology
  • Endometriosis / pathology*
  • Female
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / secondary
  • Humans
  • Ileal Neoplasms / drug therapy*
  • Ileal Neoplasms / pathology
  • Liver Neoplasms / secondary
  • Phenylurea Compounds / therapeutic use*
  • Pyridines / therapeutic use*
  • Sunitinib / therapeutic use*

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Pyridines
  • regorafenib
  • Sunitinib